For example, aberrant expression of β4-integrin is associated with breast cancer progression, and the loss of β4-integrin down-regulates the activity of the PI3K/Akt pathway9, which is a known pathway in ERBB2 expression10, 11, 12. This evidence concerns the gene ERBB2 and breast carcinoma.